Important Disclosure Information. Read Before Proceeding.
Companies
xAI
xAI
Burlingame, CA
Founded 2023
Business/Productivity Software
xAI is an AI company that seeks to understand the true nature of the universe.
x.ai|X (Twitter)|LinkedIn|Crunchbase
Last Round Valuation
$113B
Last Round Share Price
$ XX.XY
Total Funding
$12.3B
Last Round
Tender
xAI
$86.21
1M
3M
YTD
1Y
2Y
MAX
Powered by Caplight

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here
Information contained herein is based on estimates and is subject to update.

News

03/28/2026
xAI Loses 11 Co-Founders as Last Co-Founder Departs
The near-total departure of xAI’s co-founders signals talent and leadership risk that could slow product development, unsettle investors and complicate recruitment as Elon Musk consolidates control; no funding, valuation or revenue details were reported.
TechCrunch
03/25/2026
xAI Prioritizes AI Video as 0 Financial Details Disclosed
xAI's upgraded video-generator push aims to capture demand after OpenAI discontinued Sora, intensifying competition in generative video and potentially accelerating xAI productization and hiring — no funding, valuation, revenue, or per-share details were disclosed.
Bloomberg
03/20/2026
xAI Sends Engineers to Clients, Targets 2024 Enterprise Deals
By embedding engineers onsite to win corporate customers from OpenAI and Anthropic, xAI aims to speed enterprise adoption and product-market fit, though the company has disclosed no funding, valuation, revenue, ARR, or investor details.
Bloomberg

Research

xAI One-Pager
xAI vs OpenAI vs Anthropic
Why SpaceX acquired xAI
xAI revenue, growth, and valuation
Harvey at $75M ARR
Harvey One-Pager
Sam Hall, CEO of Wafer, on AI agent form factors
Perplexity One-Pager
Research reports obtained through third party are for informational purposes only.
Let us know if we are missing anything
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Are orders posted anonymously?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How can I get notified when there are new interested buyers of my shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How do Augment fees work?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
Augment
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.